Seagen’s for­mer com­mer­cial chief joins the board at health­care agency minds + as­sem­bly

Long­time on­col­o­gy com­mer­cial leader Chip Romp is mak­ing a cre­ative leap and join­ing the board of di­rec­tors at de­sign-fo­cused health­care agency minds + as­sem­bly.

Romp led com­mer­cial op­er­a­tions for Seagen for more than four years of his al­most 14-year ca­reer there, over­see­ing four of its can­cer drugs — Ad­cetris, Pad­cev, Tukysa and Tiv­dak — through launch­es and in­di­ca­tion ad­di­tions. Be­fore that, he was Genen­tech’s na­tion­al sales di­rec­tor for on­col­o­gy and im­munol­o­gy prod­ucts, in­clud­ing Avastin and Rit­ux­an.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER